Alkem Laboratories Ltd 2021 AR2
The report highlights Alkem Laboratories Limited's operational and financial performance for the fiscal year 2020-21, emphasizing its resilience during the COVID-19 pandemic. Key achievements include a revenue of INR 88,650 million, representing a 6.2% year-on-year growth, and an EBITDA margin expansion of 420 basis points to 21.9%. The company launched its first biosimilar product, Teriparatide, and expanded its international presence, particularly in the US. On the ESG front, Alkem reduced its electricity consumption by 4.85% and water intake by 12.32% across manufacturing sites. It also engaged in significant community development, including partnering with the Tata Memorial Centre to establish cancer care facilities in Bihar.
Company: Alkem Laboratories Ltd
Sector: Manufacturing
Country: India
Year: 2021
Type: AR2
Pages: 240
Back to company
Alkem Laboratories Ltd
Annual Report
The report highlights Alkem Laboratories Limited's operational and financial performance for the fiscal year 2020-21, emphasizing its resilience during the COVID-19 pandemic. Key achievements include a revenue of INR 88,650 million, representing a 6.2% year-on-year growth, and an EBITDA margin expansion of 420 basis points to 21.9%. The company launched its first biosimilar product, Teriparatide, and expanded its international presence, particularly in the US. On the ESG front, Alkem reduced its electricity consumption by 4.85% and water intake by 12.32% across manufacturing sites. It also engaged in significant community development, including partnering with the Tata Memorial Centre to establish cancer care facilities in Bihar.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Workplace Fatalities
Employees